CFTR and cystic fibrosis: The Whitcomb laboratory proposed that certain CFTR mutations that are not associated with CF may be risk factors for CP by preferentially lowering the HCO3- conductance and permeability of the CFTR channel (bicarbonate defective CFTR variants; CFTRBD) [9, 10].